MARKET

ENLV

ENLV

Enlivex Therapeutics Ltd
NASDAQ

Real-time Quotes | Nasdaq Last Sale

4.630
+0.020
+0.43%
Opening 13:17 03/31 EDT
OPEN
4.630
PREV CLOSE
4.610
HIGH
4.810
LOW
4.620
VOLUME
51.26K
TURNOVER
--
52 WEEK HIGH
44.90
52 WEEK LOW
3.590
MARKET CAP
46.83M
P/E (TTM)
-1.0493
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of ENLV and other stocks commission-free!

Open a Webull account and fund it to get a free stock

EPS

ENLV News

More
  • Enlivex reports final data from study of Allocetra in severe sepsis
  • Seeking Alpha - Article · 03/18 15:28
  • SLS, APRN among premarket gainers
  • Seeking Alpha - Article · 03/18 13:23
  • Enlivex Announces Positive Final Safety and Efficacy Data From Clinical Trial of Off-The-Shelf Allocetra in Patients with Severe Sepsis
  • GlobeNewswire · 03/18 13:00
  • INO, DXC among premarket gainers
  • Seeking Alpha - Article · 03/11 13:16

Industry

Biotechnology & Medical Research
-2.25%
Pharmaceuticals & Medical Research
-0.97%

Hot Stocks

Symbol
Price
%Change

About ENLV

Enlivex Therapeutics Ltd is an Israel-based clinical-stage company focused on specialized cell immunotherapy. The Company aims to develop and commercialize an allogeneic drug pipeline for rebalancing all manner of immune hyper-responses. The Company is developing Allocetra, a cell-based immunotherapy, for the treatment of numerous acute conditions. It rebalances a life-threatening unbalanced immune system, using the immune system’s own natural regulation mechanisms. Allocetra is designed to avert cytokine storms and restores safe immune balance, without suppressing the immune system, by engaging macrophages and dendritic cells. The Company’s clinical development programs focus on preventing or treating complications associated with bone-marrow transplantations, Sepsis and solid tumors.
More

Webull offers kinds of Enlivex Therapeutics Ltd stock information, including NASDAQ:ENLV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ENLV stock news, and many more online research tools to help you make informed decisions.